Majumdar Abha, Mangal Nisha Sharma
Departments of Obstetrics and Gynecology, Sir Ganga Ram Hospital and Sir Ganga Ram Kolmet Hospital, New Delhi, India.
J Hum Reprod Sci. 2013 Jul;6(3):168-75. doi: 10.4103/0974-1208.121400.
Prolactin (PRL) is an anterior pituitary hormone which has its principle physiological action in initiation and maintenance of lactation. In human reproduction, pathological hyperprolactinemia most commonly presents as an ovulatory disorder and is often associated with secondary amenorrhea or oligomenorrhea. Galactorrhea, a typical symptom of hyperprolactinemia, occurs in less than half the cases. Out of the causes of hyperprolactinemia, pituitary tumors may be responsible for almost 50% of cases and need to be investigated especially in the absence of history of drug induced hyperprolactinemia. In women with hyperprolactinemic amenorrhea one important consequence of estrogen deficiency is osteoporosis, which deserves specific therapeutic consideration. Problem in diagnosing and treating hyperprolactinemia is the occurrence of the 'big big molecule of prolactin' that is biologically inactive (called macroprolactinemia), but detected by the same radioimmunoassay as the biologically active prolactin. This may explain many cases of very high prolactin levels sometimes found in normally ovulating women and do not require any treatment. Dopamine agonist is the mainstay of treatment. However, presence of a pituitary macroadenoma may require surgical or radiological management.
催乳素(PRL)是一种垂体前叶激素,其主要生理作用是启动和维持泌乳。在人类生殖过程中,病理性高催乳素血症最常见的表现为排卵障碍,常与继发性闭经或月经过少相关。溢乳是高催乳素血症的典型症状,但不到半数患者会出现。在高催乳素血症的病因中,垂体肿瘤可能占近50%的病例,尤其在无药物性高催乳素血症病史的情况下需要进行检查。在高催乳素血症性闭经的女性中,雌激素缺乏的一个重要后果是骨质疏松,这值得进行特殊的治疗考虑。诊断和治疗高催乳素血症的一个问题是出现生物学上无活性的“大催乳素分子”(称为巨催乳素血症),但它通过与生物活性催乳素相同的放射免疫测定法被检测到。这可能解释了有时在正常排卵女性中发现的许多高催乳素水平病例,且这些病例不需要任何治疗。多巴胺激动剂是主要的治疗方法。然而,垂体大腺瘤的存在可能需要手术或放射治疗。